Skip to Content

TEVA 2050 TEVA 2050 (Tolterodine tartrate extended-release 2 mg)

This pill with imprint "TEVA 2050 TEVA 2050" is Green, Capsule-shape and has been identified as Tolterodine tartrate extended-release 2 mg. It is manufactured by Teva Pharmaceuticals USA Inc..

Tolterodine is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tolterodine tartrate extended-release 2 mg TEVA 2050 TEVA 2050
Tolterodine tartrate extended-release 2 mg TEVA 2050 TEVA 2050
Discount Card Promo
Tolterodine tartrate extended-release
TEVA 2050 TEVA 2050
2 mg
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.